HIPRA
LIVE

Serial Number

97243682

Owner

LABORATORIOS HIPRA S.A.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Jan 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HIPRA Trademark

Serial Number: 97243682 • Registration: 8061096

HIPRA is a trademark filed by LABORATORIOS HIPRA S.A. on January 28, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

LABORATORIOS HIPRA S.A. (17 trademarks)

Avda. de la Selva, 135

Entity Type: 99

Trademark Details

Filing Date

January 28, 2022

Registration Date

December 9, 2025

First Use in Commerce

July 23, 2024

Published for Opposition

October 24, 2023

Goods & Services

Scientific and technological services, as well as associated research and design services, namely, scientific research, analysis and testing in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices, and instruments; industrial analysis and research services in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices, and instruments, as well as of computer software related to the biomedical and pharmaceutical sector, and industrial design services; quality control services for others in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices and instruments; design and development of computer hardware and software; research and development of vaccines; veterinary laboratory services; services for assessing the effectiveness of veterinary medicines; design of laboratory animal housing systems; biotechnology research for determining the neuronal survival of molecules in animal models; research regarding farm animal breeding; genetic tests of laboratory animals for research; consultancy in pharmaceutical research; consultancy related to pharmacology; consultancy related to pharmacogenetics research; consultancy related to pharmaceutical research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; inspection of pharmaceutical products; scientific research in the field of pharmaceuticals; research in the field of pharmacogenetics; research regarding pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; conducting early evaluations in relation to new pharmaceutical products; pharmaceutical drug development services; drug discovery services; pharmaceutical product efficacy assessment services; medical and pharmacological research services; pharmaceutical research and development services; information technology services for the pharmaceutical and health-care industries, namely, information technology consulting services; provision of information regarding results of clinical trials relating to pharmaceutical products; electronic storage of medical records; design and development of medical diagnostic apparatus; scientific research for medical purposes; medical laboratories; programming for computers in the medical field; information and data services regarding medical and veterinary research and development; services of a medical laboratory; non-medical ultrasound imaging services; provision of scientific information regarding medical disorders and their treatment; research and development of vaccines and medicines; biological research and analysis; development of computer software in the pharmaceutical, medical, veterinary, sanitary and diagnostic field; clinical research in the field of veterinary preparations, biotherapeutic medicines, and antibodies; blood testing services for scientific research; scientific analysis services relating to the assessment of bacteria content in liquids

Pharmaceutical products, namely, biological vaccines for human and veterinary use; biological preparations for medical and veterinary use, namely, veterinary vaccines; veterinary preparations for the treatment of intestinal bacteria; anti- infective products for veterinary use; insecticidal washing products for veterinary use; veterinary products and substances, namely, vaccines for prevention of animal illness; biological reagents for veterinary use; diagnostic reagents for veterinary use; reagents for clinical analyses for veterinary purposes; reagents for microbiological analyses for veterinary purposes; reagents for chemical analyses for veterinary purposes; reagents for veterinary diagnosis; reagents for diagnostic tests for veterinary purposes; reagents for use with analyzers for veterinary purposes; reagents for use in analyses for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; reagents for use in analysis for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for veterinary use; reagents and media for medical and veterinary diagnostic purposes; nucleic acid sequences for medical and veterinary use; dietary supplements for veterinary use; veterinary substances and preparations, namely, vaccines for prevention of animal illness; oral vaccine preparations; vaccine preparations for human use; vaccines; influenza vaccines; vaccines against pneumococcal infections; vaccines for horses; vaccines for cattle; vaccines for infections in animal hooves; vaccines for human use; veterinary vaccines; viral vaccines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 19, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 19, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 3, 2025 SUPC
USE AMENDMENT FILED
Jun 18, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 18, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 19, 2024 EX2G
SOU EXTENSION 2 FILED
Dec 19, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 18, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 6, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 12, 2023 GNFN
FINAL REFUSAL E-MAILED
Jun 12, 2023 GNFR
FINAL REFUSAL WRITTEN
Jun 12, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 23, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 24, 2022 AMPX
ASSIGNED TO LIE
Feb 24, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 18, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2022 NWOS
NEW APPLICATION ENTERED
Feb 1, 2022 NWAP